NASDAQ:VIVE

Viveve Medical Stock Forecast, Price & News

$2.93

-0.04 (-1.35 %)

(As of 06/11/2021 12:00 AM ET)

Add

Compare

Today's Range

$2.90

▼

$3.09

50-Day Range

$2.40

▼

$3.25

52-Week Range

$2.40

▼

$14.40

Volume125,760 shs

Average Volume1.32 million shs

Market Capitalization$31.03 million

P/E RatioN/A

Dividend YieldN/A

Beta0.68

30 days | 90 days | 365 days | Advanced Chart

Receive VIVE News and Ratings via Email

Sign-up to receive the latest news and ratings for Viveve Medical and its competitors with MarketBeat's FREE daily newsletter.

About Viveve Medical

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. The company was founded in 2005 and is headquartered in Englewood, Colorado.

Head-To-Head Contrast: Helius Medical Technologies (NASDAQ:HSDT) and Viveve Medical (NASDAQ:VIVE)
June 11, 2021 | americanbankingnews.com

Viveve Medical, Inc.: Viveve Announces Issuance of New Device and Methods Patent in U.S.
June 10, 2021 | finanznachrichten.de

Viveve Announces Issuance of New Device and Methods Patent in U.S.
June 10, 2021 | finance.yahoo.com

Head-To-Head Analysis: Viveve Medical (NASDAQ:VIVE) & Star Equity (NASDAQ:STRR)
May 27, 2021 | americanbankingnews.com

Recap: Viveve Medical Q1 Earnings
May 14, 2021 | benzinga.com

Viveve Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 14, 2021 | finance.yahoo.com

Viveve Announces Adjournment of Annual Meeting
May 11, 2021 | finance.yahoo.com

Georgia Bio Applauds Passage of Senate Bill 6 and the Georgia Made Medical Manufacturing Act
May 6, 2021 | au.finance.yahoo.com

Viveve To Host Conference Call on May 13, 2021 To Report First Quarter Financial Results and Provide Corporate Update
May 6, 2021 | finance.yahoo.com

Global Vaginal Laxity Market (2021 to 2025) - Featuring Viveve Medical, Almirall, Hologic and Fotona Among Others - ResearchAndMarkets.com
May 5, 2021 | sg.finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Electromedical equipment
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:VIVE
Previous SymbolOTCMKTS:PLCSD
CUSIPN/A
CIK879682
Webwww.viveve.com
Phone720-696-8100
Employees42
Year FoundedN/A

Sales & Book Value

Annual Sales$5.48 million
Price / Sales5.66
Cash FlowN/A
Price / Cash FlowN/A
Book Value$2.60 per share
Price / Book1.13

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares10,592,000
Market Cap$31.03 million
Next Earnings Date8/12/2021 (Estimated)
OptionableOptionable

MarketRank^™

Overall MarketRank^™

0.73 out of 5 stars

Medical Sector

1307th out of 2,096 stocks

Electromedical Equipment Industry

34th out of 62 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Viveve Medical.

3.0 Community Rank

Outperform Votes
Viveve Medical has received 305 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Viveve Medical has received 208 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Viveve Medical has received 59.45% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Viveve Medical and other stocks. Vote “Outperform” if you believe VIVE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VIVE will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Viveve Medical does not currently pay a dividend.
Dividend Growth
Viveve Medical does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Viveve Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.80% of the stock of Viveve Medical is held by insiders.
Percentage Held by Institutions
Only 5.49% of the stock of Viveve Medical is held by institutions.

0.6 Earnings and Valuation

Earnings Growth
Earnings for Viveve Medical are expected to grow in the coming year, from ($2.52) to ($1.73) per share.
Price to Book Value per Share Ratio
Viveve Medical has a P/B Ratio of 1.13. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Viveve Medical (NASDAQ:VIVE) Frequently Asked Questions

Is Viveve Medical a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viveve Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Viveve Medical stock.
View analyst ratings for Viveve Medical or view top-rated stocks.

What stocks does MarketBeat like better than Viveve Medical?

Wall Street analysts have given Viveve Medical a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Viveve Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Viveve Medical's next earnings date?

Viveve Medical is scheduled to release its next quarterly earnings announcement on Thursday, August 12th 2021.
View our earnings forecast for Viveve Medical.

How were Viveve Medical's earnings last quarter?

Viveve Medical, Inc. (NASDAQ:VIVE) announced its quarterly earnings data on Thursday, May, 13th. The company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.51) by $0.29. Viveve Medical had a negative trailing twelve-month return on equity of 146.66% and a negative net margin of 400.27%.
View Viveve Medical's earnings history.

How has Viveve Medical's stock been impacted by COVID-19?

Viveve Medical's stock was trading at $0.84 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, VIVE shares have increased by 248.8% and is now trading at $2.93.
View which stocks have been most impacted by COVID-19.

Who are Viveve Medical's key executives?

Viveve Medical's management team includes the following people:

Mr. Scott C. Durbin, CEO & Director (Age 52, Pay $635.05k)
Mr. Jim B. Robbins, Sr. VP of Fin. & Admin. and Principal Accounting & Financial Officer (Age 57, Pay $350.75k)
Ms. Debora A. Jorn M.B.A., Sr. Advisor to the CEO & Director (Age 63, Pay $35k)
Mr. Martin Kerber P.E., VP of Research, Devel. & Operations
Ms. Jeannie Swindle, Sr. Director of Corp. Communications
Mr. Jeff Sinclair, VP of International Sales
Mr. Gary Kaiser, VP of Global Marketing
Ms. Lori McMillan, VP of HR
Ms. Suzon D. Lommel, Sr. VP of Regulatory & Quality Affairs (Age 63)

Who are some of Viveve Medical's key competitors?

Some companies that are related to Viveve Medical include IRIDEX (IRIX), FONAR (FONR), ENDRA Life Sciences (NDRA), Electromed (ELMD), Soleno Therapeutics (SLNO), electroCore (ECOR), Fc Global Realty (FCRE), Helius Medical Technologies (HSDT), ReShape Lifesciences (RSLS), Nuwellis (NUWE), Precision Optics (PEYE), Star Equity (STRR), Vaso (VASO), Micron Solutions (MICR) and ADM Tronics Unlimited (ADMT).
View all of VIVE's competitors.

What other stocks do shareholders of Viveve Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Viveve Medical investors own include Corbus Pharmaceuticals (CRBP), Visa (V), HP (HPQ), Fortive (FTV), Lowe's Companies (LOW), SCYNEXIS (SCYX), Western Digital (WDC), Inovio Pharmaceuticals (INO), Viking Therapeutics (VKTX) and Novavax (NVAX).

When did Viveve Medical IPO?

(VIVE) raised $13 million in an initial public offering on Tuesday, June 14th 2016. The company issued 1,600,000 shares at a price of $8.00 per share. Ladenburg Thalmann and Craig-Hallum Capital Group served as the underwriters for the IPO and Maxim Group was co-manager.

What is Viveve Medical's stock symbol?

Viveve Medical trades on the NASDAQ under the ticker symbol "VIVE."

Who are Viveve Medical's major shareholders?

Viveve Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (2.86%), Meitav Dash Investments Ltd. (0.53%), Virtu Financial LLC (0.42%), Citadel Advisors LLC (0.29%), Citadel Advisors LLC (0.28%) and UBS Group AG (0.24%).
View institutional ownership trends for Viveve Medical.

Which institutional investors are buying Viveve Medical stock?

VIVE stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Meitav Dash Investments Ltd., Virtu Financial LLC, Citadel Advisors LLC, Citadel Advisors LLC, UBS Group AG, Geode Capital Management LLC, and Goldman Sachs Group Inc..
View insider buying and selling activity for Viveve Medical or or view top insider-buying stocks.

How do I buy shares of Viveve Medical?

Shares of VIVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Viveve Medical's stock price today?

One share of VIVE stock can currently be purchased for approximately $2.93.

How much money does Viveve Medical make?

Viveve Medical has a market capitalization of $31.03 million and generates $5.48 million in revenue each year.

How many employees does Viveve Medical have?

Viveve Medical employs 42 workers across the globe.

What is Viveve Medical's official website?

The official website for Viveve Medical is www.viveve.com.

Where are Viveve Medical's headquarters?

Viveve Medical is headquartered at 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112.

How can I contact Viveve Medical?

Viveve Medical's mailing address is 345 INVERNESS DRIVE SOUTH BUILDING B SUITE 250, ENGLEWOOD CO, 80112. The company can be reached via phone at 720-696-8100 or via email at [email protected]

This page was last updated on 6/12/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here